23
Participants
Start Date
April 30, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
voriconazole
Patients must have received (in the Intensive Care Unit \[ICU\] at study entry) at least 1 day therapy with systemic antifungal agent for treatment of a proven or suspected fungal infection. The decision regarding choice of antifungal agent would lie with the treating physician and will necessarily precede and be independent of the decision to enroll a patient into the study.
Pfizer Investigational Site, Pune
Pfizer Investigational Site, Pune
Pfizer Investigational Site, New Delhi
Lead Sponsor
Pfizer
INDUSTRY